A. V. Alessenko

755 total citations
35 papers, 585 citations indexed

About

A. V. Alessenko is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, A. V. Alessenko has authored 35 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Physiology and 6 papers in Neurology. Recurrent topics in A. V. Alessenko's work include Sphingolipid Metabolism and Signaling (26 papers), Lipid Membrane Structure and Behavior (7 papers) and Neonatal Health and Biochemistry (5 papers). A. V. Alessenko is often cited by papers focused on Sphingolipid Metabolism and Signaling (26 papers), Lipid Membrane Structure and Behavior (7 papers) and Neonatal Health and Biochemistry (5 papers). A. V. Alessenko collaborates with scholars based in Russia, United States and Italy. A. V. Alessenko's co-authors include Elisabetta Albi, А. Е. Бугрова, Subroto Chatterjee, Yusuf A. Hannun, E. B. Burlakova, Alexey Khrenov, W A Khan, N Sahyoun, Sabine Grösch and William C. Wetsel and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

A. V. Alessenko

32 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. V. Alessenko Russia 13 438 146 103 54 54 35 585
Daan M. van den Brink Netherlands 12 390 0.9× 111 0.8× 87 0.8× 83 1.5× 93 1.7× 17 587
Qiuhong Duan China 17 426 1.0× 112 0.8× 58 0.6× 42 0.8× 30 0.6× 46 782
Shuvadeep Maity India 12 409 0.9× 79 0.5× 160 1.6× 29 0.5× 50 0.9× 21 642
Museer A. Lone Switzerland 14 585 1.3× 149 1.0× 234 2.3× 34 0.6× 78 1.4× 26 742
Kimiko Mogami Japan 12 426 1.0× 134 0.9× 117 1.1× 27 0.5× 88 1.6× 16 668
Eleonora Paradies Italy 11 702 1.6× 176 1.2× 68 0.7× 20 0.4× 115 2.1× 18 922
Ismail Kaddour‐Djebbar United States 17 405 0.9× 76 0.5× 60 0.6× 43 0.8× 24 0.4× 25 695
Thomas Briston United Kingdom 8 460 1.1× 169 1.2× 51 0.5× 94 1.7× 23 0.4× 10 723
Birgit Honrath Germany 13 435 1.0× 86 0.6× 84 0.8× 33 0.6× 24 0.4× 16 678

Countries citing papers authored by A. V. Alessenko

Since Specialization
Citations

This map shows the geographic impact of A. V. Alessenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Alessenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Alessenko more than expected).

Fields of papers citing papers by A. V. Alessenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Alessenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Alessenko. The network helps show where A. V. Alessenko may publish in the future.

Co-authorship network of co-authors of A. V. Alessenko

This figure shows the co-authorship network connecting the top 25 collaborators of A. V. Alessenko. A scholar is included among the top collaborators of A. V. Alessenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. V. Alessenko. A. V. Alessenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alessenko, A. V., et al.. (2021). The role of sphingolipids in pathogenesis of amyotrophic lateral sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 121(8). 131–131.
2.
Alessenko, A. V., et al.. (2020). The role of lipids in the pathogenesis of lateral amyotrophic sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 120(10). 108–108.
3.
Alessenko, A. V. & Elisabetta Albi. (2020). Exploring Sphingolipid Implications in Neurodegeneration. Frontiers in Neurology. 11. 437–437. 101 indexed citations
4.
Alessenko, A. V., et al.. (2019). Lipidome features in patients with different probability of family hypercholesterolemia. Bulletin of Russian State Medical University. 84–91. 1 indexed citations
5.
Maloshitskaya, Olga A., Sergey Sokolov, S. Yu. Funikov, et al.. (2019). Changes in the Metabolism of Sphingoid Bases in the Brain and Spinal Cord of Transgenic FUS(1-359) Mice, a Model of Amyotrophic Lateral Sclerosis. Biochemistry (Moscow). 84(10). 1166–1176. 12 indexed citations
6.
Alessenko, A. V., et al.. (2016). Tumor necrosis factor-alpha - potential target for neuroprotector dimebon. Biomeditsinskaya Khimiya. 62(4). 418–425. 2 indexed citations
7.
Alessenko, A. V., et al.. (2015). Tumor necrosis factor-alpha is a potential target for the neuroprotector Dimebon. Biochemistry (Moscow) Supplement Series B Biomedical Chemistry. 9(2). 189–198.
8.
9.
Alessenko, A. V., et al.. (2008). Relationship between parameters of lipid peroxidation during obstructive jaundice and after bile flow restoration. Bulletin of Experimental Biology and Medicine. 145(1). 33–36. 1 indexed citations
10.
11.
Alessenko, A. V., et al.. (2005). The relation between sphingomyelinase activity, lipid peroxide oxidation and NO‐releasing in mice liver and brain. FEBS Letters. 579(25). 5571–5576. 18 indexed citations
12.
Alessenko, A. V., et al.. (2002). Role of Tumor Necrosis Factor Alpha and Sphingomyelin Cycle Activation in the Induction of Apoptosis by Ischemia/Reperfusion of the Liver. Biochemistry (Moscow). 67(12). 1347–1355. 12 indexed citations
13.
Alessenko, A. V. & E. B. Burlakova. (2002). Functional role of phospholipids in the nuclear events. Bioelectrochemistry. 58(1). 13–21. 39 indexed citations
14.
EVSTIGNEEVA, R. P., et al.. (2001). Effects of Reduced and Oxidized Glutathione on Sphingomyelinase Activity and Contents of Sphingomyelin and Lipid Peroxidation Products in Murine Liver. Biochemistry (Moscow). 66(9). 1028–1034. 15 indexed citations
15.
Khrenov, Alexey, et al.. (2001). Effect of Bilirubin on Lipid Peroxidation, Sphingomyelinase Activity, and Apoptosis Induced by Sphingosine and UV Irradiation. Biochemistry (Moscow). 66(9). 1019–1027. 13 indexed citations
16.
Alessenko, A. V. & Alexey Khrenov. (1999). Role of sphingosine in induced apoptosis. Lipids. 34(S1Part1). S75–6. 9 indexed citations
17.
18.
Alessenko, A. V., et al.. (1997). Mechanisms of cycloheximide‐induced apoptosis in liver cells. FEBS Letters. 416(1). 113–116. 39 indexed citations
19.
Alessenko, A. V. & Subroto Chatterjee. (1995). Neutral sphingomyelinase: Localization in rat liver nuclei and involvement in regeneration/proliferation. Molecular and Cellular Biochemistry. 143(2). 169–174. 52 indexed citations
20.
Khan, W A, et al.. (1992). Sphingosine activation of protein kinases in Jurkat T cells. In vitro phosphorylation of endogenous protein substrates and specificity of action.. Journal of Biological Chemistry. 267(21). 15246–15251. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daan M. van den Brink Breakdown of academic impact, for papers by Qiuhong Duan Breakdown of academic impact, for papers by Shuvadeep Maity Breakdown of academic impact, for papers by Museer A. Lone Breakdown of academic impact, for papers by Kimiko Mogami Breakdown of academic impact, for papers by Eleonora Paradies Breakdown of academic impact, for papers by Ismail Kaddour‐Djebbar Breakdown of academic impact, for papers by Thomas Briston Breakdown of academic impact, for papers by Birgit Honrath
Rankless by CCL
2026